Interim Site Head

Successfully led corporate restructuring, strategy realignment and workforce reduction to improve operational efficiency

Acted as Works Council Chair before serving as Managing Director, ensuring stable change management and employee alignment during a reduction of the workforce from 150 to 30 employees

Led the successful restructuring and reorganization of CDMO as the managing director

Close to 30 years of experience in the pharmaceutical and biotechnological sector

Advising the new Corporate CEO on post-merger integration topics

Focus on the integration and alignment of the organization

Support in establishing a unified quality structure across the organization

Sparring partner on quality-related integration decisions in a GMP-regulated environment

Led revitalization of corporate strategy and development pipeline in endocrinology and immunology

Directed in-licensing of preclinical projects and technology platforms

Oversaw investor relations activities and public financing processes

Streamlined internal processes and ensured compliance with GMP and GCP requirements

Reconstructed the company’s financial foundations and prevented insolvency

Restructured Finance and Investor Relations functions

Executed multiple successful capital raises on Nasdaq, securing multi-million-dollar funding within two years

Defined company vision, mission and long-term strategic objectives

Developed and executed business plans and led the executive management team

Secured the subsidiary’s financial stability and ensured compliance with German regulatory requirements

Executed a comprehensive company restructuring to improve operational efficiency

Established and advanced an innovative development pipeline and ensured clinical development execution

Built and maintained a strong oversight and leadership team supporting strategic delivery

Defined and implemented quality assurance strategies aligned with corporate objectives

Led and developed the Quality Assurance organization

Ensured GMP compliance for commercial product supply to another pharmaceutical company

Managed GMP and GCP compliance for clinical development programs

Coordinated and successfully supported US FDA pre-approval inspections on-site and at CDMOs, enabling approval of a new drug in the US and Europe

Elected Works Council Chairman, responsible for managing and leading negotiations related to workforce downsizing